薬物乱用検査の世界市場規模・シェア・開発・成長・需要予測(2013~2023年):商品別(簡易検査キット、アッセイキット・試薬、免疫測定分析装置、クロマトグラフィー装置、呼吸分析装置)・サンプルタイプ別(尿、唾液、髪の毛)・エンドユーザー別(病院、ラボ、在宅、オフィス)・地域別(米国、イギリス、ドイツ、フランス、イタリア、日本、中国、インド、ブラジル)

P&S Market Researchが発行した調査報告書(PSM802036)
◆英語タイトル:Drug of Abuse (DOA) Testing Market by Product (Rapid Test Kits, Assay Kits & Reagents, Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers), by Sample Type (Urine, Saliva, Hair), by End User (Hospital, Laboratory, At Home, Workplace), by Geography (U.S., U.K., Germany, France, Italy, Japan, China, India, Brazil) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023
◆商品コード:PSM802036
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2017年9月1日
◆ページ数:188
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,100 ⇒換算¥561,000見積依頼/購入/質問フォーム
Group License(5名様閲覧用)USD6,100 ⇒換算¥671,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,100 ⇒換算¥1,001,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はP&S Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。P&S Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Various samples such as urine, hair and saliva are used for the testing of drug of abuse. The drug of abuse testing market is growing due to technological advancements taking place that increase sensitivity, reduce consumption of time, and facilitate detection of newly developed designer drugs. The increased use of drug of abuse tests for legal and medical purposes has made it imperative to produce results with high confidence levels. As a result, improvement can be observed in various facets such as chemistry, materials, device and equipment.
Due to increasing consumption of illicit drugs and consecutive initiatives taken by government and other organizations for reducing drug abuse levels are making the organizations aware regarding the need for drug of abuse testing. Other than that, the rise in road accidents and death rates, increased use of drug of abuse testing at organizational level and increased production and trade of illicit drugs worldwide are also the driving the demand for drug of abuse testing products.

Insights on market segments

As per the findings of the research, consumables held the larger share in the drug of abuse testing market in 2016, since consumable are easily available for use and provide rapid test results when compared to equipment. Rapid test kits are used at a large scale and its consumption is expected to increase at faster rate during the forecast period, since they are easy to use and provide result in a short span of time, as compared to assay kits & reagents.

The key players in the drug of abuse testing industry provide equipment such as immunoassay analyzers, chromatographic analyzers and breath analyzers. Among all the equipment, breath analyzers market size is projected to grow at the fastest rate, with a CAGR of 9.5% during the forecast period since they can detect the presence of drugs and alcohol in the breath easily in a short span of time, and are less expensive than other analyzers.

North America stands as the largest drug of abuse testing market

Geographically, North America has been the largest market for drug of abuse testing market, with the U.S. being the larger contributor to the regional market, as compared to rest of North America. The leading position of the North American market is mainly due to the increased availability of illicit drugs, rising workplace monitoring for consumption of illicit drugs and increased drug trafficking in the region.

According to National Institute on Drug Abuse (NIDA), in 2013, an estimated 24.6 million Americans aged 12 years or above, constituting approximately 9.4% of the total population, had used an illicit drug, which was an increase of 8.3% from 2002. The increase was mainly due to rise in the use of marijuana, the most commonly used illicit drug.

Key players in the market are acquiring other firms to gain a larger market share

Globally, the key players in the drug of abuse testing market are acquiring other companies to gain a larger market share in the industry. For instance, in January 2017, Sonic Healthcare Limited acquired Medical Laboratory Bremen, a laboratory in the North-West of Germany. The acquisition was aimed at expanding the former’s presence in Germany and strengthen the company’s commitment to medical leadership in laboratory medicine. The purchase price of $66.8 million (cash and debt free) was funded in Euro from Sonic Healthcare Limited’s existing cash and debt facilities.

【レポートの目次】

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Sample Type

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Market Segmentation

4.1.1 By Product

4.1.1.1 Consumable

4.1.1.1.1 Rapid test kits

4.1.1.1.2 Assay kits & reagents

4.1.1.1.3 Others

4.1.1.2 Equipment

4.1.1.2.1 Immunoassay analyzers

4.1.1.2.2 Chromatography instruments

4.1.1.2.3 Breath analyzers

4.1.2 By Sample Type

4.1.2.1 Urine

4.1.2.2 Saliva

4.1.2.3 Hair

4.1.2.4 Others

4.1.3 By End User

4.1.3.1 Hospitals

4.1.3.2 Laboratories

4.1.3.3 Workplace

4.1.3.4 At home

4.1.3.5 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Mergers & acquisitions

4.2.1.2 Increasing number of product launches

4.2.2 Drivers

4.2.2.1 Increased use of drug of abuse testing at organizational level

4.2.2.2 Increased production and trade of illicit drugs worldwide

4.2.2.3 Global increase in road accidents and death rates

4.2.2.4 Increase in consumption of illegal drugs

4.2.2.5 Technological advancements in drug of abuse testing market

4.2.2.6 Initiatives by government and other organizations to reduce drug abuse levels

4.2.2.7 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Legalization of illicit drugs

4.2.3.2 Social issues associated with drug of abuse testing

4.2.3.3 Inability to detect low-dose designer drugs

4.2.3.4 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Threat of New Entrants

4.3.4 Intensity of Rivalry

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 Global Drug of Abuse Testing Market, by Product

5.1.1 Global Drug of Abuse Testing Consumable Market, by Type

5.1.2 Global Drug of Abuse Testing Equipment Market, by Type

5.2 Global Drug of Abuse Testing Market, by Sample Type

5.3 Global Drug of Abuse Testing Market, by End User

5.4 Global Drug of Abuse Testing Market, by Region

Chapter 6. North America Market Size and Forecast

6.1 North America Drug of Abuse Testing Market

6.1.1 North America Drug of Abuse Testing Market, by Product

6.1.1.1 North America drug of abuse testing consumable market, by type

6.1.1.2 North America drug of abuse testing equipment market, by type

6.1.2 North America Drug of Abuse Testing Market, by Sample Type

6.1.3 North America Drug of Abuse Testing Market, by End User

6.1.4 North America Drug of Abuse Testing Market, by Country

Chapter 7. Europe Market Size and Forecast

7.1 Europe Drug of Abuse Testing Market

7.1.1 Europe Drug of Abuse Testing Market, by Product

7.1.1.1 Europe drug of abuse testing consumable market, by type

7.1.1.2 Europe drug of abuse testing equipment market, by type

7.1.2 Europe Drug of Abuse Testing Market, by Sample Type

7.1.3 Europe Drug of Abuse Testing Market, by End User

7.1.4 Europe Drug of Abuse Testing Market, by Country

Chapter 8. Asia–Pacific Market Size and Forecast

8.1 Asia-Pacific Drug of Abuse Testing Market

8.1.1 Asia-Pacific Drug of Abuse Testing Market, by Product

8.1.1.1 Asia-Pacific drug of abuse testing consumable market, by type

8.1.1.2 Asia-Pacific drug of abuse testing equipment market, by type

8.1.2 Asia-Pacific Drug of Abuse Testing Market, by Sample Type

8.1.3 Asia-Pacific Drug of Abuse Testing Market, by End User

8.1.4 Asia-Pacific Drug of Abuse Testing Market, by Country

Chapter 9. Rest of the World Market Size and Forecast

9.1 Rest of the World (RoW) Drug of Abuse Testing Market

9.1.1 RoW Drug of Abuse Testing Market, by Product

9.1.1.1 RoW drug of abuse testing consumable market, by type

9.1.1.2 RoW drug of abuse testing equipment market, by type

9.1.2 RoW Drug of Abuse Testing Market, by Sample Type

9.1.3 RoW Drug of Abuse Testing Market, by End User

9.1.4 RoW Drug of Abuse Testing Market, by Country

Chapter 10. Competitive Landscape

10.1 Product Benchmarking of Key Players

10.2 Global Strategic Developments of Key Players

10.2.1 Merger and Acquisition

10.2.2 Product Launch/Approval

10.2.3 Partnership

10.2.4 Other Developments

Chapter 11. Company Profiles

11.1 Danaher Corporation

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.1.3 Key Financial Summary

11.1.4 Strategic Growth Plans

11.2 Siemens AG

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.2.3 Key Financial Summary

11.2.4 Strategic Growth Plans

11.3 Merck KGaA

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.3.3 Key Financial Summary

11.3.4 Strategic Growth Plans

11.4 Shimadzu Corporation

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.4.3 Key Financial Summary

11.4.4 Strategic Growth Plans

11.5 Drägerwerk AG & Co. KGaA

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.5.3 Key Financial Summary

11.5.4 Strategic Growth Plans

11.6 Express Diagnostics Int’l, Inc.

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.6.3 Strategic Growth Plans

11.7 bioMérieux S.A.

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.7.3 Key Financial Summary

11.7.4 Strategic Growth Plans

11.8 Waters Corporation

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.8.3 Key Financial Summary

11.8.4 Strategic Growth Plans

11.9 Roche Holding AG

11.9.1 Business Overview

11.9.2 Product and Service Offerings

11.9.3 Key Financial Summary

11.9.4 Strategic Growth Plans

11.10 Quest Diagnostics Inc.

11.10.1 Business Overview

11.10.2 Product and Service Offerings

11.10.3 Key Financial Summary

11.10.4 Strategic Growth Plans

11.11 Laboratory Corporation of America Holdings

11.11.1 Business Overview

11.11.2 Products and Service Offerings

11.11.3 Key Financial Summary

11.11.4 Strategic Growth Plans

11.12 Alere Inc.

11.12.1 Business Overview

11.12.2 Product and Service Offerings

11.12.3 Strategic Growth Plans

11.13 Abbott Laboratories

11.13.1 Business Overview

11.13.2 Product and Service Offerings

11.13.3 Key Financial Summary

11.13.4 Strategic Growth Plans

11.14 Randox Laboratories Ltd

11.14.1 Business Overview

11.14.2 Product and Service Offerings

11.14.3 Strategic Growth Plans

11.15 Psychemedics Corporation

11.15.1 Business Overview

11.15.2 Product and Service Offerings

11.15.3 Key Financial Summary

11.15.4 Strategic Growth Plans

11.16 Bio-Rad Laboratories, Inc.

11.16.1 Business Overview

11.16.2 Product and Service Offerings

11.16.3 Key Financial Summary

11.16.4 Strategic Growth Plans

11.17 Sonic Healthcare Ltd.

11.17.1 Business Overview

11.17.2 Product and Service Offerings

11.17.3 Key Financial Summary

11.17.4 Strategic Growth Plans

11.18 ThermoFisher Scientific Inc.

11.18.1 Business Overview

11.18.2 Product and Services

11.18.3 Key Financial Summary

11.18.4 Strategic Growth Plans

Chapter 12. Appendix

12.1 Abbreviations

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 GLOBAL DRUG OF ABUSE TESTING MARKET SNAPSHOT

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 6 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 7 GLOBAL DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 8 GLOBAL DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 9 GLOBAL DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 10 GLOBAL DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 11 GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 12 GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 13 GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 14 GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER $M (2017 – 2023)

TABLE 15 GLOBAL DRUG OF ABUSE TESTING MARKET, BY REGION, $M (2013 – 2016)

TABLE 16 GLOBAL DRUG OF ABUSE TESTING MARKET, BY REGION, $M (2017 – 2023)

TABLE 17 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 18 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 19 NORTH AMERICA DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 20 NORTH AMERICA DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 21 NORTH AMERICA DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 22 NORTH AMERICA DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 23 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 24 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 25 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 26 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 27 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 28 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 29 EUROPE DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 30 EUROPE DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 31 EUROPE DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 32 EUROPE DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 33 EUROPE DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 34 EUROPE DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 35 EUROPE DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 36 EUROPE DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 37 EUROPE DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 38 EUROPE DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 39 EUROPE DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 40 EUROPE DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 41 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 42 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 43 ASIA-PACIFIC DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 44 ASIA-PACIFIC DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 45 ASIA-PACIFIC DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 46 ASIA-PACIFIC DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 47 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 48 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 49 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 50 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 51 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 52 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 53 ROW DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 54 ROW DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 55 ROW DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 56 ROW DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 57 ROW DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2016)

TABLE 58 ROW DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2017 – 2023)

TABLE 59 ROW DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2016)

TABLE 60 ROW DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2017 – 2023)

TABLE 61 ROW DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2016)

TABLE 62 ROW DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2017 – 2023)

TABLE 63 ROW DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 64 ROW DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 65 DANAHER CORPORATION– AT A GLANCE

TABLE 66 DANAHER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 67 SIEMENS AG – AT A GLANCE

TABLE 68 SIEMENS AG – KEY FINANCIAL SUMMARY

TABLE 69 MERCK KGAA – AT A GLANCE

TABLE 70 MERCK KGAA – KEY FINANCIAL SUMMARY

TABLE 71 SHIMADZU CORPORATION – AT A GLANCE

TABLE 72 SHIMADZU CORPORATION – KEY FINANCIAL SUMMARY

TABLE 73 DRÄGERWERK AG & CO. KGAA– AT A GLANCE

TABLE 74 DRAGERWERK AG & CO. KGAA – KEY FINANCIAL SUMMARY

TABLE 75 EXPRESS DIAGNOSTICS INT’L, INC.– AT A GLANCE

TABLE 76 BIOMÉRIEUX S.A. – AT A GLANCE

TABLE 77 BIOMÉRIEUX S.A. – KEY FINANCIAL SUMMARY

TABLE 78 WATERS CORPORATION – AT A GLANCE

TABLE 79 WATERS CORPORATION – KEY FINANCIAL SUMMARY

TABLE 80 ROCHE HOLDING AG – AT A GLANCE

TABLE 81 ROCHE HOLDING AG – KEY FINANCIAL SUMMARY

TABLE 82 QUEST DIAGNOSTICS INC.– AT A GLANCE

TABLE 83 QUEST DIAGNOSTICS INC. – KEY FINANCIAL SUMMARY

TABLE 84 LABORATORY CORPORATION OF AMERICA HOLDINGS – AT A GLANCE

TABLE 85 LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FINANCIAL SUMMARY

TABLE 86 ALERE INC. – AT A GLANCE

TABLE 87 ABBOTT LABORATORIES – AT A GLANCE

TABLE 88 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY

TABLE 89 RANDOX LABORATORIES LTD. – AT A GLANCE

TABLE 90 PSYCHEMEDICS CORPORATION – AT A GLANCE

TABLE 91 PSYCHEMEDICS CORPORATION – KEY FINANCIAL SUMMARY

TABLE 92 BIO-RAD LABORATORIES, INC.– AT A GLANCE

TABLE 93 BIO-RAD LABORATORIES, INC. – KEY FINANCIAL SUMMARY

TABLE 94 SONIC HEALTHCARE LTD.– AT A GLANCE

TABLE 95 SONIC HEALTHCARE LTD. – KEY FINANCIAL SUMMARY

TABLE 96 THERMOFISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 97 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

LIST OF FIGURES

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 PORTER’S FIVE FORCES ANALYSIS

FIG 9 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT (2016)

FIG 10 GLOBAL DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 11 GLOBAL DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 12 GLOBAL DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 13 GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 14 GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER $M (2013 – 2023)

FIG 15 WORLDWIDE MAJOR MARKETS FOR GLOBAL DRUG OF ABUSE TESTING

FIG 16 NORTH AMERICA DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 17 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 18 NORTH AMERICA DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 19 NORTH AMERICA DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 20 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 21 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 22 NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 23 EUROPE DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 24 EUROPE DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 25 EUROPE DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 26 EUROPE DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 27 EUROPE DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 28 EUROPE DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 29 EUROPE DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 30 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 31 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 32 ASIA-PACIFIC DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 33 ASIA-PACIFIC DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 34 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 35 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 36 ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 37 ROW DRUG OF ABUSE TESTING MARKET SNAPSHOT

FIG 38 ROW DRUG OF ABUSE TESTING MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 39 ROW DRUG OF ABUSE TESTING CONSUMABLE MARKET, BY TYPE, $M (2013 – 2023)

FIG 40 ROW DRUG OF ABUSE TESTING EQUIPMENT MARKET, BY TYPE, $M (2013 – 2023)

FIG 41 ROW DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE, $M (2013 – 2023)

FIG 42 ROW DRUG OF ABUSE TESTING MARKET, BY END USER, $M (2013 – 2023)

FIG 43 ROW DRUG OF ABUSE TESTING MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 44 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 45 DANAHER CORPORATION REVENUE SPLIT BY SEGMENT (2016)

FIG 46 DANAHER CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 47 SIEMENS AG REVENUE SPLIT BY SEGMENT (2016)

FIG 48 SIEMENS AG REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 49 MERCK KGAA REVENUE SPLIT BY SEGMENT (2016)

FIG 50 MERCK KGAA REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 51 SHIMADZU CORPORATION REVENUE SPLIT BY SEGMENT (2016)

FIG 52 SHIMADZU CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 53 DRAGERWERK AG & CO. KGAA REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 54 BIOMÉRIEUX SA REVENUE SPLIT BY APPLICATION (2016)

FIG 55 BIOMÉRIEUX SA REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 56 WATERS CORPORATION REVENUE SPLIT BY SEGMENT (2016)

FIG 57 WATERS CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 58 ROCHE HOLDING AG REVENUE SPLIT BY SEGMENT (2016)

FIG 59 QUEST DIAGNOSTICS INC. REVENUE SPLIT BY SEGMENT (2016)

FIG 60 LABORATORY CORPORATION OF AMERICA HOLDINGS REVENUE SPLIT BY SEGMENT (2016)

FIG 61 LABORATORY CORPORATION OF AMERICA HOLDINGS REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 62 PSYCHEMEDICS CORPORATION REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 63 BIO-RAD LABORATORIES, INC. REVENUE SPLIT BY SEGMENT (2016)

FIG 64 BIO-RAD LABORATORIES, INC. REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 65 SONIC HEALTHCARE LTD. REVENUE SPLIT BY SEGMENT (2016)

FIG 66 SONIC HEALTHCARE LTD. REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 67 THERMOFISHER SCIENTIFIC INC. REVENUE SPLIT BY SEGMENT (2016)

FIG 68 THERMOFISHER SCIENTIFIC INC. REVENUE SPLIT BY GEOGRAPHY (2016)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 薬物乱用検査の世界市場規模・シェア・開発・成長・需要予測(2013~2023年):商品別(簡易検査キット、アッセイキット・試薬、免疫測定分析装置、クロマトグラフィー装置、呼吸分析装置)・サンプルタイプ別(尿、唾液、髪の毛)・エンドユーザー別(病院、ラボ、在宅、オフィス)・地域別(米国、イギリス、ドイツ、フランス、イタリア、日本、中国、インド、ブラジル)(Drug of Abuse (DOA) Testing Market by Product (Rapid Test Kits, Assay Kits & Reagents, Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers), by Sample Type (Urine, Saliva, Hair), by End User (Hospital, Laboratory, At Home, Workplace), by Geography (U.S., U.K., Germany, France, Italy, Japan, China, India, Brazil) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆